Physician profile
William Ashley
NPI 1033238647
$6,767.73
in general payments reported to CMS, 2019-2025
20 companies · $1,359 in 2025
The $1,359 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,150 · 2020: $448 · 2021: $419 · 2022: $546 · 2023: $467 · 2024: $378 · 2025: $1,359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,204.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,344.76 | 2021-2025 | Solitaire X, Axium Primetm, Pipeline |
| Depuy Synthes Sales INC. | $1,078.74 | 2019-2025 | Embotrap, Cerebase |
| Medtronic USA, INC. | $1,034.50 | 2019-2020 | |
| Microvention, INC. | $947.73 | 2019-2024 | Web Aneurysm Embolization System, Stent, Azur Cx Detachable |
| Stryker Corporation | $743.40 | 2019-2025 | Duramatrix, Trevo, Core |
| Penumbra, INC. | $323.24 | 2019 | |
| Balt USA, LLC | $257.14 | 2019-2022 | |
| Route 92 Medical, INC. | $253.62 | 2024-2025 | 8f Base Camp Sheath System |
| Rapid Medical Ltd | $137.62 | 2025 | Tigertriever 17 Revascularization Device, Comaneci 17 |
| Orthofix Medical, INC. | $126.00 | 2019 | |
| Medical Device Business Services, INC. | $125.00 | 2023 | Emboguard |
| Abbott Laboratories | $114.37 | 2019-2024 | Perclose Prostyle, Xact, Acculink |
| Portola Pharmaceuticals, LLC | $96.36 | 2019 | |
| Abbvie INC. | $76.50 | 2023-2025 | Botox |
| Ucb, INC. | $34.92 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $23.16 | 2019 | |
| Allergan, INC. | $18.52 | 2021 | |
| Chiesi USA, INC. | $17.17 | 2019 | |
| Lemaitre Vascular, INC. | $14.98 | 2024 | Anastoclip Gc 8cm (Medium) |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Ashley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.